Why the Same Low-Dose Pill Can Affect Hair Loss So Differently — Dr. Moriwaki Sorts Out Female Hair Risk by the Progestin Androgenic Activity of Each Formulation and Positions Stem Cell Conditioned Media2026.07.23
“I feel like my hair started falling out more after I began taking the pill,” or “I switched to another pill and stopped worrying about it” — these are voices we sometimes hear in the consultation room. Low-dose oral contraceptives (OC) and low-dose estrogen-progestin combinations (LEP) prescribed for dysmenorrhea contain progestins that differ substantially between generations, and their progestin androgenic activity is by no means uniform. To discuss the effect on hair under the single label of “the pill,” a deeper understanding is needed. In this column, Dr. Moriwaki of AVAN TOKYO Ginza reviews the way female hair loss risk should be read from these ingredient differences, and where stem cell conditioned media fits as an option.
Key Points of This Article
・Progestin androgenic activity differs by generation, and its effect on female hair is not uniform
・First- and second-generation synthetic progestins tend to retain relatively more androgen-like action
・Third- and fourth-generation progestins (desogestrel, drospirenone, etc.) are designed to suppress androgenic activity
・Telogen effluvium can appear 2–4 months after stopping the pill, and lining up the timing is the first step in differential diagnosis
・Stem cell conditioned media is not a substitute for hormonal therapy but a supportive option that underpins the follicular environment
What Is a Progestin? The Border Between Female and Male Hormones
Progestins are synthetic compounds designed to mimic the action of the corpus luteum hormone (progesterone). Their chemical structure differs slightly from natural progesterone, and these small structural differences generate a wide range in pharmacological action. Particularly important is affinity for the androgen receptor. Many progestins are derived from a testosterone-based skeleton, and to varying degrees they retain male-hormone-like action (androgenic activity).
What Androgenic Activity Means at the Hair Follicle
Hair follicles on the female crown and frontal scalp express 5-alpha reductase, which converts testosterone into dihydrotestosterone (DHT). In sensitive follicles, DHT shortens the anagen phase of the hair cycle and drives miniaturization of the hair shaft. Progestins with strong androgenic activity can act in a direction that stimulates the follicles of women with a genetic predisposition to FAGA (female-pattern hair loss), and depending on individual constitution, this may be perceived as worsening hair loss.
Four Generations Divided by Progestin Androgenic Activity
Progestins contained in low-dose pills and LEP are conventionally classified into four generations based on their development period and structural characteristics. Understanding the features of each helps clarify where the product you are taking sits on this map.
First generation (norethisterone)
An older type, considered to retain relatively more androgen-like action. It is also used to treat dysmenorrhea, but depending on constitution, users may notice androgen-like symptoms such as increased sebum, acne, or hair loss.
Second generation (levonorgestrel)
Excellent for contraception and menstrual control, yet its progestin androgenic activity is positioned as relatively strong among first- and second-generation options. Cases have been reported where women with a family history of FAGA start to notice hair loss several months after initiation.
Third generation (desogestrel)
Designed to suppress androgenic activity, with relatively fewer reports of androgen-like side effects such as sebum overproduction, acne, and hair loss.
Fourth generation (drospirenone)
Structurally similar to the diuretic spironolactone and known to exhibit anti-androgenic activity. It is sometimes prescribed with the aim of improving hirsutism or acne. Attention is still required from other perspectives such as thromboembolic risk.
How to Approach Hair Loss During and After Pill Use
Progestin androgenic activity is an important axis when discussing effects on hair, but another phenomenon must not be overlooked in real practice — telogen effluvium after pill discontinuation. When a pill taken for a long period is discontinued, the abrupt shift in hormonal environment can synchronize many follicles into the telogen phase, in a mechanism similar to postpartum hair loss, and hair shedding may increase with a delay of 2–4 months.
First, line up the “timing”
The first step is to line up the period when hair loss became noticeable with the timing of pill initiation, change, or discontinuation. Whether it began immediately after starting, around three months after stopping, or in an unrelated period changes the differential and the response dramatically. Sharing information with the prescribing gynecologist and, when necessary, evaluating other contributors such as thyroid function, iron, and ferritin, is desirable.
Do not switch pills on your own judgment
It is dangerous to oversimplify by saying, “Switching to a pill with lower androgenic activity will stop the hair loss.” A pill is a medication that should be chosen along multiple axes: contraceptive efficacy, menstrual control, thrombotic risk, and cost. Rather than switching solely because of hair, judgment ideally comes from cooperation between the gynecologist and a hair specialist. For further reading on FAGA, please also see our list of related columns on hair regenerative medicine.
Where Stem Cell Conditioned Media Fits — Not a Substitute for Hormonal Therapy but a Supporting Layer
Stem cell conditioned media cannot cancel out the follicular stimulation that progestin androgenic activity may cause. However, the varied growth factors it contains (IGF-1, HGF, VEGF, KGF, and others) and cytokines are suggested at the basic research level to have the potential to calm microinflammation around the follicle, regulate microcirculation, and support the maintenance of the anagen phase. Clarifying the division of roles — correcting the hormonal background is the job of gynecology and endocrinology, while supporting the scalp environment is the job of hair regenerative medicine — is the trick to not breaking treatment design. For general guidance on medical decision frameworks regarding hair and skin, please also refer to the guidelines of the Japanese Dermatological Association as you consider individual applicability.
What to expect and what not to over-expect
Stem cell conditioned media is not an “all-purpose regenerator” but a treatment with individual variation and clear limits. For pill-related hair loss, evaluating the hormonal environment on the causative side comes first; only then does positioning conditioned media as a supportive move to sustain the scalp environment become an honest construction.
Frequently Asked Questions
Q. My hair loss seems to have increased since I started the pill. Should I stop it immediately?
We do not recommend discontinuing on your own. Discontinuation can itself trigger telogen effluvium. First, consult the prescribing gynecologist to sort out the relationship between initiation timing and hair loss, and if necessary, receive evaluation from a hair specialist.
Q. If I switch to a drospirenone-containing pill with anti-androgenic action, will hair loss always improve?
Not necessarily. Progestin androgenic activity is one factor influencing hair, but constitution, genetic background, nutritional status, stress, and other elements are also involved. Switching should be judged from a comprehensive perspective that includes not only hair but also thrombotic risk and other factors.
Q. I stopped the pill. When will the hair loss settle down?
Typically, hair loss increases 2–4 months after discontinuation and gradually settles over the following 3–6 months. If improvement remains poor after more than a year, we recommend evaluation for other causes such as thyroid dysfunction, iron deficiency, or FAGA progression.
Q. Can I receive stem cell conditioned media scalp treatment while on the pill?
In principle, concurrent use is possible. It does not neutralize the hormonal background caused by the pill, but with the aim of regulating the microenvironment around the follicle, it can be introduced after discussing individual applicability with a physician.
Q. Can stem cell conditioned media alone completely stop female hair loss?
Complete assurance cannot be given. When causes clearly lie in hormonal background, nutritional deficiency, or systemic disease, correcting those takes priority. Conditioned media is a supporting treatment and finds meaning when combined with treatment of the cause.
──────────────
Supervising physician: Shin Moriwaki, MD
Member, Japan Society of Aesthetic Surgery (JSAS)
Member, American Academy of Aesthetic Medicine
ECFMG Certificate
──────────────
📍AVAN TOKYO 銀座 毛髪再生医療
AVAN TOKYO Ginza Hair Regenerative Medicine
English / 中文 / Tiếng Việt available
Inquiries welcome via DM / LINE / Website / Phone.